Incidence of pulmonary hypertension in patients with chronic myeloproliferative disorders

Journal of the National Medical Association

Volumn 98, Issue 11, 2006, Pages 1779-1782

  Gupta, Ranju ^a   Perumandla, Sirisha ^a   Patsiornik, Yelena ^a   Niranjan, Selvanayagam ^a   Ohri, Anju ^a  

^a State University of New York Health Science Center   (United States)

Author keywords

Chronic myeloid leukemia; Chronic myeloproliferative disease; Essential thrombocytosis; Polycythemia vera; Pulmonary hypertension

Indexed keywords

ACETYLSALICYLIC ACID; ANAGRELIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HEART EJECTION FRACTION; HEMATOCRIT; HUMAN; INCIDENCE; MALE; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE COUNT; THROMBOCYTOSIS; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; COMORBIDITY; FEMALE; HEMATOCRIT; HUMANS; HYPERTENSION, PULMONARY; INCIDENCE; MALE; MIDDLE AGED; MYELOPROLIFERATIVE DISORDERS; PLATELET COUNT; POLYCYTHEMIA VERA; PROSPECTIVE STUDIES; THROMBOCYTOSIS;

EID: 33845370433     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Nand S, Orfrei E. Pulmonary hypertension in polycythemia vera. Am J Hematol. 1994;47:242-244.
2. Rostango C, Prisco D, Abatte R, et al. Pulmonary hypertension associated with long standing thrombocytosis. Chest. 1991;99:1303-1305.
3. Garcia-Manero G, Schuster SJ, Patrick H, et al. Pulmonary hypertension in patients with myelofibrosis secondary to myeloproliferative diseases. Am J Hematol. 1999;60:130-135.
4. Dingli D, Utz JP, Krowka MJ, et al. Unexplained pulmonary hypertension in chronic myeloproliferative disorders. Chest. 2001;120:801-808.
5. Garypidou V, Vakalopoulou S, Dimitriadis D, et al. Incidence of pulmonary hypertension in patients with chronic myeloproliferative disorders. Haematologica. 2004;89:245-246.
6. Reisner SA, Rinkevich D, Markiewicz W, et al. Cardiac involvement in patients with myeloproliferative disorders. Am J Med. 1992;93:498-504.
7. Marvin KS, Spellberg RD. Pulmonary hypertension secondary to thrombocytosis in a patient with myeloid metaplasia. Chest. 1993;103:642-644.
8. Tefferi A. Myelofibrosis with myeloid metaplasia. N Eng J Med. 2000;342:1255-1265.
9. Tefferi A, Silverstein MN, Hoagland HC. Primary thrombocythemia. Semin Oncol. 1995;22:334-340.
10. Tefferi A. Polycythemia vera: a comprehensive review and clinical recommendations. Mayo Clin Proc. 2003;78:174-94.
11. Rubin LJ. Primary pulmonary hypertension. N Eng J Med. 1997;336:1466-1470.
12. Martin-Duran R, Larman M, Trugeda A, et al. Comparison of Doppler-determined elevated pulmonary arterial pressure with pressure measured at cardiac catheterization. Am J Cardiol. 1986;57:859-863.
13. Rubin LJ, Barst RT, Kaiser LR, et al. Primary pulmonary hypertension. Chest. 1993;104:236-250.
14. Kadikoylu G, Onbasili A, Tekten T, et al. Functional and morphological cardiac changes in myeloproliferative disorders (clinical study). Int J Cardiol. 2004;97:213-220.
15. Einsfelder BM, Muller KM. Pulmonary hypertension in chronic myeloproliferative disorders. Pathologe. 2005;26(3):169-177. German.
16. Haznedaroglu IC, Atalar E, Ozturk MA, et al. Thrombopoietin inside the pulmonary vessels in patients with and without pulmonary hypertension. Platelets. 2002;13:395-399.